Who Bears The Burden Of Medicaid Drug Copayment Policies?-Reference-Cited by-同舟云学术

Who Bears The Burden Of Medicaid Drug Copayment Policies?

Published:1999-03 Issue:2 Volume:18 Page:201-212
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Stuart Bruce¹,Zacker Christopher¹

Affiliation:

1. Bruce Stuart is the Parke-Davis Professor of Geriatric Pharmacotherapy at the University of Maryland's School of Pharmacy in Baltimore. Christopher Zacker is manager, outcomes research, at Novartis Pharmaceutical Corporation in East Hanover, New Jersey.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference13 articles.

1. Pharmaceutical Benefits under State Medicaid Programs ( Reston, Va. : National Pharmaceutical Council , 1996 ), 3 – 24 .

2. Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes

3. Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes

4. Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence of patients to antihypertensive drugs in the ambulance of family physician at Primary Health Care Centre Cetinje;Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma;2023

2. Association Between Medicaid Prescription Drug Limits and Access to Medications and Health Care Use Among Young Adults With Disabilities;JAMA Health Forum;2021-06-17

3. Cost sharing for breast cancer hormone therapy: How do dual eligible patients’ copayment impact adherence;PLOS ONE;2021-05-18

4. Evaluation and improvement of adherence to medication;Journal of the Korean Medical Association;2021-02-10

5. Association between insurance cost-sharing subsidy and postoperative opioid prescription refills among Medicare patients;Surgery;2020-08